5th World Congress scleroderma
Scleroderma The 5th World Congress will be in Bordeaux from 15 to 18 February 2018.
The International porphyrias & Porphyrins Congress will be in Bordeaux from 25 to 28 June 2017
6th Congress Autophagy BORDEAUX - 2016 - CFATG
ANNUAL CONGRESS OF RESEARCH DERMATOLOGIQUE
ANNUAL CONGRESS OF RESEARCH DERMATOLOGIQUE : CARD Paris
6 and 7 December 2016, PALAIS DES CONGRÈS.
Vitiligo International Symposium
2nd Workshop of Regenerative Medicine, Bordeaux 24-26 October 2016
Bordeaux has been chosen to organize the 2019 edition of the European Society for Dermatological Research (ESDR). This annual congress gathers around 1000 investigative dermatologists and researchers, mostly from Europe, but a strong American and Asian participation is expected. Before Bordeaux, Munich (2016), Salzburg (2017), and Orlando (international Investigative Dermatology IID) will be hosting the meeting. The local organizing committee will start preparing this prestigious event very soon.
46th annual ESDR meeting
7-10 September 2016
The 46th Annual ESDR Meeting will be held at the Technical University campus in Garching, a short distance from the centre of Munich. The meeting has its own website at.
The newly established « AquiDerm Cellule de Transfert » funded in part by Région Aquitaine is building on previously established network with dermocosmetics companies to develop a better valorisation of the know-how of the Dermatology team. In 2014, a technician position has been funded together with an equipment for metabolomics. The plan over 3 years is to create two further full time positions of technician/engineer which a part-time devoted to basic research in academic projects.
Vitiligo is the most common depigmenting disorder, with a prevalence of approximately 1% in the world population. This disease involves complex combinatorial pathogenic effects, multiple susceptibility genes and unknown environmental triggers. A loss of epidermal melanocytes is the pathogenic hallmark of vitiligo. The dermatology team has a long lasting interest in pigmentary disorders especially vitiligo and has developed tools to model pigmented skin ex vivo for the last two decades. The major goal of the newly created ATIP-Avenir project is to develop a basic research program on inflammatory dermatoses, in particular vitiligo, which benefits already of an established clinical research programme.